(Q43944829)

28 November 2017

title

Dyspepsia tolerability from the patients' perspective: a comparison of celecoxib with diclofenac (English)

1 reference

28 November 2017

1 reference

Goldstein JL

1

1 reference

28 November 2017

Eisen GM

2

1 reference

28 November 2017

Burke TA

3

1 reference

28 November 2017

Peña BM

4

1 reference

28 November 2017

Lefkowith J

5

1 reference

28 November 2017

Geis GS

6

1 reference

28 November 2017

language of work or name

English

0 references

publication date

1 April 2002

1 reference

Alimentary Pharmacology & Therapeutics

28 November 2017

published in

1 reference

28 November 2017

volume

16

1 reference

28 November 2017

issue

4

1 reference

28 November 2017

page(s)

819-827

1 reference

Epidemiology of nonsteroidal anti-inflammatory drug-associated gastrointestinal injury

28 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2002.01219.X

Misoprostol reduces serious gastrointestinal complications in patients with rheumatoid arthritis receiving nonsteroidal anti-inflammatory drugs. A randomized, double-blind, placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2002.01219.X

Treatment of osteoarthritis with celecoxib, a cyclooxygenase-2 inhibitor: a randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2002.01219.X

Celecoxib versus diclofenac in long-term management of rheumatoid arthritis: randomised double-blind comparison.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2002.01219.X

Comparison of upper gastrointestinal toxicity of rofecoxib and naproxen in patients with rheumatoid arthritis. VIGOR Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2002.01219.X

Gastrointestinal toxicity with celecoxib vs nonsteroidal anti-inflammatory drugs for osteoarthritis and rheumatoid arthritis: the CLASS study: A randomized controlled trial. Celecoxib Long-term Arthritis Safety Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2002.01219.X

Celecoxib versus diclofenac in the management of osteoarthritis of the knee

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2002.01219.X

Gastrointestinal tract complications of nonsteroidal anti-inflammatory drug treatment in rheumatoid arthritis. A prospective observational cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2002.01219.X

SODA (severity of dyspepsia assessment): a new effective outcome measure for dyspepsia-related health

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2002.01219.X

Reliability, validity, and responsiveness of severity of dyspepsia assessment (SODA) in a randomized clinical trial of a COX-2-specific inhibitor and traditional NSAID therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2002.01219.X

Experimental esophagitis induced by acid and pepsin in rabbits mimicking human reflux esophagitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2002.01219.X

10.1046/J.1365-2036.2002.01219.X

21 January 2018

Identifiers

DOI

1 reference

28 November 2017

1 reference